Page 8 - Peginterferon Lambda News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Eiger BioPharmaceuticals to Participate in Upcoming September 2021 Investor Conferences
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eiger BioPharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eiger BioPharmaceuticals to Participate in Upcoming August 2021 Investor Conferences
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eiger BioPharmaceuticals Announces First Patients Dosed with Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Eiger to add Peginterferon Lambda to Covid-19 trial in Brazil 04 May 2021 (Last Updated May 4th, 2021 12:09)
Eiger BioPharmaceuticals has said that its investigational agent, Peginterferon Lambda, will be added to the Phase III TOGETHER platform study of Covid-19 outpatients in Brazil.
Share Article
The study is enrolling Covid-19 patients at 11 sites in Brazil. Credit: Wilfried Pohnke from Pixabay.
Eiger BioPharmaceuticals has said that its investigational agent, Peginterferon Lambda, will be added to the Phase III TOGETHER platform study of Covid-19 outpatients in Brazil.
A type III interferon (IFN), Lambda induces immune responses required for developing host protection during viral infections. Eiger licensed the therapeutic from Bristol-Myers Squibb.